Utilizamos cookies de terceros para mejorar nuestros productos y servicios mediante el análisis de sus hábitos de navegación. Al aceptar el presente aviso o seguir navegando entendemos que da su consentimiento a nuestra Política de Cookies.
The pharma industry offer an essential service to society that has become even more valuable in recent times due to the crisis caused by the SARS-CoV-2 Coronavirus. This is why very specific conditions are necessary in their logistical handling, ensuring a correct traceability of their supply chain in order to guarantee a careful and safe handling.
The pharmaceutical sector and, in particular, associated logistics has traditionally been very demanding in terms of productivity, quality and availability. To this must be added the strict regulation that rules the sector that imposes, not only special storage and treatment conditions for the merchandise, but also correct traceability. These two factors drive advances in intralogistics, automatic and semi-automatic technologies.
In the laboratory and pharmaceutical logistics area, where it is so important to ensure the correct traceability of the product as to comply with the Commission Delegated Regulation (EU) 2016/161 (which entered into force at the beginning of this 2019 and that hardened the processes to prevent the entry of counterfeit medicines into the legal supply chain) it is vitally important to have a careful handling of the product and reliable material handling systems that support each process.
In the last 10 years, acquisition of automatic guided vehicles (AGV robots) for facilities in a different areas has grown significantly globally. Over time, AGV robots have proven to be able to provide numerous advantages to various areas, particularly significantly increasing the efficiency of operations in warehouses and the management of logistics processes.